» Articles » PMID: 34230477

Lack of Consideration of Sex and Gender in COVID-19 Clinical Studies

Overview
Journal Nat Commun
Specialty Biology
Date 2021 Jul 7
PMID 34230477
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Sex and gender differences impact the incidence of SARS-CoV-2 infection and COVID-19 mortality. Furthermore, sex differences influence the frequency and severity of pharmacological side effects. A large number of clinical trials to develop new therapeutic approaches and vaccines for COVID-19 are ongoing. We investigated the inclusion of sex and/or gender in COVID-19 studies on ClinicalTrials.gov, collecting data for the period January 1, 2020 to January 26, 2021. Here, we show that of the 4,420 registered SARS-CoV-2/COVID-19 studies, 935 (21.2%) address sex/gender solely in the context of recruitment, 237 (5.4%) plan sex-matched or representative samples or emphasized sex/gender reporting, and only 178 (4%) explicitly report a plan to include sex/gender as an analytical variable. Just eight (17.8%) of the 45 COVID-19 related clinical trials published in scientific journals until December 15, 2020 report sex-disaggregated results or subgroup analyses.

Citing Articles

Expanding the women's health paradigm beyond reproductive boundaries.

Munshi H, Khan T, Anand S, Gajbhiye R Indian J Med Res. 2025; 161(1):38-42.

PMID: 40036110 PMC: 11878696. DOI: 10.25259/IJMR_1428_2024.


Evaluating Covid-19 publications for sex and gender-specific health content: A bibliometric analysis.

Oyasu A, Salter-Volz A, Yeh C, Muhammad L, Jagsi R, Woitowich N PLoS One. 2025; 20(2):e0316812.

PMID: 39970134 PMC: 11838872. DOI: 10.1371/journal.pone.0316812.


The impact of sex/gender-specific funding and editorial policies on biomedical research outcomes: a cross-national analysis (2000-2021).

Kim H, Park J, Ahn S, Lee H Sci Rep. 2024; 14(1):26599.

PMID: 39496696 PMC: 11535369. DOI: 10.1038/s41598-024-77018-0.


Gender sensitivity of the COVID-19 mental health research in Europe: a scoping review.

Lopez-Atanes M, Saenz-Herrero M, Zach N, Lakeberg M, Ugedo A, Fraile-Garcia E Int J Equity Health. 2024; 23(1):207.

PMID: 39385280 PMC: 11465889. DOI: 10.1186/s12939-024-02286-1.


Handgrip strength as a prognostic factor for COVID-19 mortality among older adult patients admitted to the intensive care unit (ICU): a comparison Alpha (B.1.1.7) and Delta (B.1.617.2) variants.

Rostamzadeh S, Allafasghari A, Allafasghari A, Abouhossein A Sci Rep. 2024; 14(1):19927.

PMID: 39198687 PMC: 11358457. DOI: 10.1038/s41598-024-71034-w.


References
1.
Franconi F, Campesi I, Colombo D, Antonini P . Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies. Cells. 2019; 8(5). PMC: 6562815. DOI: 10.3390/cells8050476. View

2.
Wenham C, Smith J, Morgan R . COVID-19: the gendered impacts of the outbreak. Lancet. 2020; 395(10227):846-848. PMC: 7124625. DOI: 10.1016/S0140-6736(20)30526-2. View

3.
North C, Dougan M, Sacks C . Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond. N Engl J Med. 2020; 383(15):1406-1408. DOI: 10.1056/NEJMp2019989. View

4.
Franconi F, Campesi I . Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol. 2013; 171(3):580-94. PMC: 3969074. DOI: 10.1111/bph.12362. View

5.
Mahase E . Covid-19: US suspends Johnson and Johnson vaccine rollout over blood clots. BMJ. 2021; 373:n970. DOI: 10.1136/bmj.n970. View